NeuroOne Medical Technologies Corporation
NMTC
$0.80
-$0.01-0.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.00% | 70.73% | 55.90% | 48.43% | 46.64% |
| Total Depreciation and Amortization | 3.48% | 6.00% | 6.61% | 7.86% | 14.00% |
| Total Amortization of Deferred Charges | -159.32% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.04% | -60.11% | -41.65% | -16.00% | 34.11% |
| Change in Net Operating Assets | 80.69% | 55.04% | 92.86% | 98.46% | -71.65% |
| Cash from Operations | 11.92% | 74.23% | 64.63% | 58.78% | 47.03% |
| Capital Expenditure | 8.74% | 32.03% | 23.35% | 70.12% | 73.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 8.74% | 32.03% | 19.04% | -110.69% | -104.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 112.13% | 63.76% | -5.61% | -73.36% | -53.14% |
| Repurchase of Common Stock | -47.91% | -53.19% | -64.21% | -282.71% | 40.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -196.57% | -198.64% | 117.43% | 203.07% | 193.26% |
| Cash from Financing | 56.36% | 10.45% | 5.93% | -61.28% | -35.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 256.94% | 232.31% | 538.65% | 4.55% | 22.14% |